Realistic Recruitment Expectations Require Disease and Geographic Considerations
Applied Clinical Trials Online: Sep 24, 2013 Companies that seek to set realistic recruitment expectations should consider using key enrollment benchmarks which combine both disease and geographic information. This permits a more accurate view of enrollment performance based on the differences across regions within a given disease. Read more
More Voices Enter Clinical Trials Data Sharing Debate in Europe
Phrma: 9/20/13 A new paper released this week highlights issues surrounding the discussions on clinical trial data sharing. The paper, Clinical Trials and Data Transparency: The Public Interest Case, highlights specific problems to the current draft European Medicines Agency (EMA). Among the problems highlighted were gaps in the protection of patient privacy, further bureaucratization of an already bureaucratic system and conflicting policies on regulatory […]
ACRO’s new video series about the importance of clinical research
Research America: September 11, 2013 Clinical research is key to saving lives, lowering health care costs and reducing waste and inefficiencies in our health care system. To highlight the latest insights from prominent health and research leaders, The Association of Clinical Research Organization has launched a new video series about the importance of clinical research. In the latest […]
Patients have a right to participate in risky research
MNT: Sep 18, 2013 Individuals have a right to participate in risky research trials, which might harm their health or even kill them, and institutional review boards (known as research ethics committees in the UK) – which are responsible for deciding whether a particular research trial can take place in a given institution – are […]
Impact of patient involvement in mental health research: longitudinal study
Bjp.rcpsych: September 12, 2013 It is deemed good practice to involve patients routinely in research but no study has investigated the practical benefits, particularly to successful recruitment. Aims To identify whether patient involvement is associated with study success. Method All studies listed on the Mental Health Research Network (MHRN) portfolio database (n = 374) were interrogated using […]
NIH scientists pursue new therapies to improve rare disease drug development
NIH: September 12, 2013 Four new pre-clinical drug development projects at the National Institutes of Health will target a form of blindness and diseases characterized by cardiac problems. The projects were selected for their potential to treat specific rare diseases and to help scientists uncover new information that can be shared with other researchers. The […]
More Than 270 Vaccines in Biopharmaceutical Pipeline Offer Hope to Prevent/Treat Wide Array of Diseases
Phrma.: 9/11/13 WASHINGTON, D.C. (September 11, 2013) – America’s biopharmaceutical companies are currently developing 271 vaccines to prevent – and in some cases treat – a variety of conditions, including infectious diseases, various forms of cancer and neurological disorders, according to a new report by the Pharmaceutical Research and Manufacturers of America (PhRMA). The report is being released in […]
